About the project
An Inspire client was developing clinical trial protocols for scleroderma-associated interstitial lung disease (SSc-ILD). The client approached Inspire with three goals:
- Understand patient disease burden
- Evaluate clinical trial protocols
- Develop a trial recruitment strategy based on patient preference.
Inspire collected awareness and sentiment data using quantitative surveys (n=50). Patient preferences were further refined using virtual patient interviews.
- Quantitative surveys were fully-fielded in 14 days with translations, moderation, and native transcripts provided by Inspire
- Patients were located across the U.S., France, and Germany
Benefit to the client
As a result of our research, the client could make more informed decisions about clinical trial design and recruitment strategies, ensuring adequate and timely enrollment and higher rates of study completion.
Inspire provided our client with:
Insights for how best to educate and alleviate concerns among potential trial participants
Key learnings to help inform trial design, eligibility criteria, and study length
